These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 31585940

  • 1. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.
    Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB.
    Cancer Res; 2019 Nov 15; 79(22):5758-5768. PubMed ID: 31585940
    [Abstract] [Full Text] [Related]

  • 2. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.
    Gustafsson A, Fritz HKM, Dahlbäck B.
    Exp Cell Res; 2017 Jun 01; 355(1):47-56. PubMed ID: 28327411
    [Abstract] [Full Text] [Related]

  • 3. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.
    Rankin EB, Fuh KC, Castellini L, Viswanathan K, Finger EC, Diep AN, LaGory EL, Kariolis MS, Chan A, Lindgren D, Axelson H, Miao YR, Krieg AJ, Giaccia AJ.
    Proc Natl Acad Sci U S A; 2014 Sep 16; 111(37):13373-8. PubMed ID: 25187556
    [Abstract] [Full Text] [Related]

  • 4. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
    Gustafsson A, Boström AK, Ljungberg B, Axelson H, Dahlbäck B.
    PLoS One; 2009 Oct 30; 4(10):e7575. PubMed ID: 19888345
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, Ljungberg B, Dahlbäck B.
    Clin Cancer Res; 2009 Jul 15; 15(14):4742-9. PubMed ID: 19567592
    [Abstract] [Full Text] [Related]

  • 6. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
    Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch E.
    Oncogene; 2016 May 15; 35(21):2687-97. PubMed ID: 26364599
    [Abstract] [Full Text] [Related]

  • 7. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
    Chen TJ, Mydel P, Benedyk-Machaczka M, Kamińska M, Kalucka U, Blø M, Furriol J, Gausdal G, Lorens J, Osman T, Marti HP.
    Physiol Rep; 2021 Dec 15; 9(23):e15140. PubMed ID: 34877810
    [Abstract] [Full Text] [Related]

  • 8. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.
    Hakozaki K, Tanaka N, Takamatsu K, Takahashi R, Yasumizu Y, Mikami S, Shinojima T, Kakimi K, Kamatani T, Miya F, Tsunoda T, Aimono E, Nishihara H, Mizuno R, Oya M.
    Br J Cancer; 2021 Nov 15; 125(11):1533-1543. PubMed ID: 34611307
    [Abstract] [Full Text] [Related]

  • 9. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET, Chaturvedi P, Lopez DTM, Lippman ME.
    Mol Cancer Ther; 2020 Jul 15; 19(7):1462-1473. PubMed ID: 32371578
    [Abstract] [Full Text] [Related]

  • 10. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A, de Gregorio E, Cucarull B, Cristóbal H, Aresté C, Graupera I, Coll M, Colell A, Gausdal G, Lorens JB, García de Frutos P, Morales A, Marí M.
    Cell Mol Gastroenterol Hepatol; 2020 Jul 15; 9(3):349-368. PubMed ID: 31689560
    [Abstract] [Full Text] [Related]

  • 11. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q, Li O, Zheng W, Xiao WZ, Zhang L, Wu D, Cai GY, He JC, Chen XM.
    Cell Death Dis; 2017 May 11; 8(5):e2772. PubMed ID: 28492542
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies.
    Kariolis MS, Miao YR, Diep A, Nash SE, Olcina MM, Jiang D, Jones DS, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ.
    J Clin Invest; 2017 Jan 03; 127(1):183-198. PubMed ID: 27893463
    [Abstract] [Full Text] [Related]

  • 13. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.
    Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS.
    Br J Cancer; 2015 Aug 11; 113(4):616-25. PubMed ID: 26180925
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
    Tanaka M, Siemann DW.
    Int J Mol Sci; 2021 Sep 15; 22(18):. PubMed ID: 34576116
    [Abstract] [Full Text] [Related]

  • 15. Luteolin inhibits angiogenesis by blocking Gas6/Axl signaling pathway.
    Li X, Chen M, Lei X, Huang M, Ye W, Zhang R, Zhang D.
    Int J Oncol; 2017 Aug 15; 51(2):677-685. PubMed ID: 28627676
    [Abstract] [Full Text] [Related]

  • 16. Gas6-induced tissue factor expression in endothelial cells is mediated through caveolin-1-enriched microdomains.
    Laurance S, Aghourian MN, Jiva Lila Z, Lemarié CA, Blostein MD.
    J Thromb Haemost; 2014 Aug 15; 12(3):395-408. PubMed ID: 24354620
    [Abstract] [Full Text] [Related]

  • 17. An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
    Kariolis MS, Miao YR, Jones DS, Kapur S, Mathews II, Giaccia AJ, Cochran JR.
    Nat Chem Biol; 2014 Nov 15; 10(11):977-83. PubMed ID: 25242553
    [Abstract] [Full Text] [Related]

  • 18. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.
    Dong M, Xiao Q, Hu J, Cheng F, Zhang P, Zong W, Tang Q, Li X, Mao F, He Y, Yu X, Wan F, Lei T, Guo D, Wang B.
    Cancer Gene Ther; 2020 Dec 15; 27(12):878-897. PubMed ID: 31988476
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic aspects of the Axl/Gas6 molecular system.
    Di Stasi R, De Rosa L, D'Andrea LD.
    Drug Discov Today; 2020 Dec 15; 25(12):2130-2148. PubMed ID: 33002607
    [Abstract] [Full Text] [Related]

  • 20. Sunitinib activates Axl signaling in renal cell cancer.
    van der Mijn JC, Broxterman HJ, Knol JC, Piersma SR, De Haas RR, Dekker H, Pham TV, Van Beusechem VW, Halmos B, Mier JW, Jiménez CR, Verheul HM.
    Int J Cancer; 2016 Jun 15; 138(12):3002-10. PubMed ID: 26815723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.